- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 211/18 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
Patent holdings for IPC class C07D 211/18
Total number of patents in this class: 146
10-year publication summary
7
|
6
|
18
|
13
|
9
|
7
|
10
|
5
|
9
|
3
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
The United States of America, as represented by the Secretary, Department of Health and Human Services | 2822 |
5 |
Massachusetts Institute of Technology | 9942 |
4 |
BioLegend, Inc. | 51 |
4 |
Toyama Chemical Co., Ltd. | 103 |
4 |
Vividion Therapeutics, Inc. | 32 |
4 |
Bristol-myers Squibb Company | 4848 |
3 |
F. Hoffmann-La Roche AG | 7889 |
3 |
California Institute of Technology | 3953 |
3 |
The Broad Institute, Inc. | 1753 |
3 |
Incyte Holdings Corporation | 652 |
3 |
Research Triangle Institute | 408 |
3 |
Schering Corporation | 484 |
3 |
SRX Cardio, LLC | 21 |
3 |
Taisho Pharmaceutical Co., Ltd. | 853 |
3 |
AstraZeneca AB | 2934 |
2 |
Boehringer Ingelheim International GmbH | 4732 |
2 |
Syngenta Crop Protection AG | 5891 |
2 |
Bayer Pharma AG | 1058 |
2 |
Abbvie Inc. | 1783 |
2 |
Agro-kanesho Co., Ltd. | 48 |
2 |
Other owners | 86 |